GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,456.50p
   
  • Change Today:
    -4.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,382.00
  • Currency: UK Pounds
  • Shares Issued: 4,145.09m
  • Volume: 4,385,490
  • Market Cap: £60,373m
  • RiskGrade: 129
  • Beta: 0.02

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 8,052.00 7,376.00 7,076.00 8,739.00 8,899.00
Operating Profit/(Loss) 573.00 1,868.00 492.00 1,061.00 1,902.00
Profit Before Tax 379.00 1,626.00 303.00 821.00 1,711.00
Profit After Tax 398.00 1,625.00 420.00 839.00 1,517.00
Discontinued Operations          
Profit After Tax n/a n/a 510.00 n/a n/a
PROFIT FOR THE PERIOD 398.00 1,625.00 930.00 839.00 1,517.00
           
Continuing EPS          
Earnings per Share - Basic 8.60p 37.20p 10.60p 13.40p 26.20p
Earnings per Share - Diluted 8.50p 36.60p 10.60p 13.40p 25.90p
Earnings per Share - Adjusted 28.90p 25.80p 10.60p 23.30p 24.80p
Continuing and Discontinued EPS          
Earnings per Share - Basic 8.60p 37.10p 18.70p 13.40p 26.20p
Earnings per Share - Diluted 8.50p 36.50p 18.70p 13.40p 25.90p
Earnings per Share - Adjusted 28.90p 25.80p 18.70p 23.30p 24.80p
Dividend per Share 16.00p 13.75p 23.00p 23.00p 23.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Total Non-Current Assets 40,361.00 39,377.00 60,429.00 60,184.00 60,201.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 59,005.00 60,146.00 79,103.00 80,431.00 79,692.00
Total Liabilities 46,210.00 50,050.00 57,761.00 59,623.00 61,335.00
Net Assets 12,795.00 10,096.00 21,342.00 20,808.00 18,357.00
           
Shareholders Funds 13,347.00 10,598.00 15,055.00 14,587.00 11,984.00
Minority Interests/Other Equity (552.00) (502.00) 6,287.00 6,221.00 6,373.00
Total Equity 12,795.00 10,096.00 21,342.00 20,808.00 18,357.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page